Daiwa Securities Group Inc. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 262 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$05390.0%0.00%
Q2 2023$05390.0%0.00%
Q1 2023$0
-100.0%
5390.0%0.00%
Q4 2022$1
-100.0%
5390.0%0.00%
Q3 2022$2,0000.0%5390.0%0.00%
Q2 2022$2,000
-33.3%
5390.0%0.00%
Q1 2022$3,000
-57.1%
5390.0%0.00%
Q4 2021$7,000
-36.4%
539
-14.4%
0.00%
Q3 2021$11,000
+83.3%
630
+74.5%
0.00%
Q2 2021$6,000
-14.3%
3610.0%0.00%
Q1 2021$7,000
+16.7%
361
+7.1%
0.00%
Q4 2020$6,000
-62.5%
337
-66.1%
0.00%
Q3 2020$16,000
-11.1%
9930.0%0.00%
Q2 2020$18,0000.0%9930.0%0.00%
Q1 2020$18,000
-14.3%
9930.0%0.00%
Q4 2019$21,000
-85.2%
993
-87.3%
0.00%
-100.0%
Q3 2019$142,000
-45.2%
7,820
+7.6%
0.00%
-50.0%
Q2 2019$259,000
+5.7%
7,270
-0.3%
0.00%0.0%
Q1 2019$245,000
+2.1%
7,2940.0%0.00%0.0%
Q4 2018$240,000
-44.1%
7,294
+3.5%
0.00%
-50.0%
Q3 2018$429,000
+34.1%
7,044
+7.6%
0.00%
+33.3%
Q2 2018$320,000
+188.3%
6,544
+527.4%
0.00%
+200.0%
Q1 2018$111,0001,0430.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders